“A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 Weeks for the Treatment of Psoriatic Arthritis”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s312. https://doi.org/10.25251/skin.8.supp.312.